Major drugmakers are filing lawsuits against the HHS and HRSA to try to resuscitate plans to issue hospitals rebates instead ...

Despite growing revenues, most major insurers saw their profits from offering health plans shrink in the third quarter as ...

Donald Trump’s first term as president was characterized by significant turbulence for government healthcare programs. Here’s ...

Mass General Brigham, Emory and other providers will assess different AI models from companies like Google, Microsoft and ...

Regulators’ assessment of customer support centers has spurred recent lawsuits from insurers. But the metric “is going to ...

The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals rebates for two drugs in the 340B drug ...

The Franklin, Tennessee-based operator has not purchased a hospital in years. That may soon change as CHS' margins improve.

Do to others what you would want done to yourself,” Medicaid director Daniel Tsai said Thursday when asked about advice for ...

Saum Sutaria doesn't think the ACA marketplace is going anywhere under President-elect Donald Trump, noting beneficiaries are ...

The nomination of a prominent vaccine skeptic to the head of the nation’s largest healthcare program is expected to alarm ...

The drug distributor will buy a majority stake in gastroenterology practice management group GI Alliance and purchase ...

The plan requires only copays for medical services and prescription drugs up to the plan member’s out-of-pocket maximum, with ...